Improving nutrition support for head and neck cancer patients
Nutrition Throughout the Treatment Course - Expanding Care From Hospital to Home
This study tests if using a diet recording app to provide personalized nutrition support can help head and neck cancer patients avoid malnutrition and improve their quality of life during treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 125 (estimated) |
| Ages | 18 Years to 99 Years |
| Sex | All |
| Sponsor | University of Oslo Academic / other |
| Locations | 2 sites (Oslo and 1 other locations) |
| Trial ID | NCT05997329 on ClinicalTrials.gov |
What this trial studies
This project focuses on addressing malnutrition in patients with head and neck cancer, a condition affecting a significant percentage of this patient population. It will implement remote patient monitoring and tailored nutrition support throughout the treatment course using a diet recording app. The effectiveness of this approach will be evaluated through a randomized controlled trial, aiming to reduce malnutrition prevalence and enhance the quality of life for participants. The study will involve collaboration between the University of Oslo and Oslo University Hospital.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years diagnosed with head and neck cancer.
Not a fit: Patients with stage 4 malignant tumors or terminal conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve nutritional status and quality of life for patients undergoing treatment for head and neck cancer.
How similar studies have performed: While there is ongoing research in nutrition support for cancer patients, this specific approach using remote monitoring is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Head and neck cancer * Older than 18 years Exclusion Criteria: * Patients admitted with the classification of malignant tumors (TNM) stage 4 * Terminal condition (life expectancy \< 6 months) * Patients who do not understand the Norwegian language.
Where this trial is running
Oslo and 1 other locations
- University of Oslo — Oslo, Norway (Not_yet_recruiting)
- Oslo University Hospital — Oslo, Norway (Recruiting)
Study contacts
- Study coordinator: Christine Henriksen, PhD
- Email: christine.henriksen@medisin.uio.no
- Phone: +4799003128
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.